Logo

Pharsight, Sanofi-Synthelabo Ink PKS Deal

Sep 26, 2002

NEW YORK, Sept. 26 - Pharsight today said French biotech company Sanofi-Synthelabo Recherche will use its Knowledgebase software for drug discovery.

 

The deal is the third in two months for the Mountain View, Calif., company: Over two weeks in August Pharsight penned similar deals with Organon and Schering-Plough.

Breaking News
The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.